Mc. Houston, THE MANAGEMENT OF HYPERTENSION AND ASSOCIATED RISK-FACTORS FOR THE PREVENTION OF LONG-TERM CARDIAC COMPLICATIONS, Journal of cardiovascular pharmacology, 21, 1993, pp. 190000002-190000013
The management of essential hypertension can no longer be directed tow
ard an isolated reduction in arterial pressure. Optimal reduction in t
he risk factors associated with hypertension and cardiovascular diseas
e hopefully will reduce coronary heart disease, angina, fatal and nonf
atal myocardial infarction, left ventricular hypertrophy, congestive h
eart failure, and sudden death. Hypertension is a genetic and acquired
syndrome that consists of dyslipidemia, insulin resistance and carboh
ydrate intolerance, central obesity, renal abnormalities, structural a
bnormalities of smooth muscle, and ion transport abnormalities (membra
nopathy). The selection of pharmacologic agents should improve the com
ponents of the hypertensive syndrome by utilizing the ''subsets of hyp
ertension approach'' to treatment.